Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

3.950 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,713
Open 3.950
Bid (Size) 3.960 (10)
Ask (Size) 3.990 (5)
Prev. Close 3.950
Today's Range 3.950 - 3.950
52wk Range 1.680 - 4.300
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Geron (GERN) Q1 2024 Earnings Call Transcript
GERN earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
GERN Stock Earnings: Geron Beats EPS, Beats Revenue for Q1 2024
GERN stock results show that Geron beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+84.58%
+84.58%
1 Month
+27.42%
+27.42%
3 Month
+105.73%
+105.73%
6 Month
+121.91%
+121.91%
1 Year
+47.94%
+47.94%

More News

Read More
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
From Geron Corporation
Via Business Wire
The Top 3 Penny Stocks to Buy in April 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Navigating 10 Analyst Ratings For Geron
Via Benzinga
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
Via Benzinga
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
From Geron Corporation
Via Business Wire
3 Red-Hot Biotech Rockets Blasting Off in 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
The Latest Analyst Ratings For Geron
Via Benzinga
Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading
Via Investor Brand Network
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
Via Benzinga
Geron to Participate at Upcoming Investor Conferences in April
From Geron Corporation
Via Business Wire
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
Via MarketBeat
Exposures Product Safety
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
What's Going On With Cancer Focused-Geron Stock On Friday?
Via Benzinga
Exposures Product Safety
Why Is Geron (GERN) Stock Up 94% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Geron Stock Is Soaring After Hours: What's Going On?
Via Benzinga
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
From Geron Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.